Dicloxacillin sodium monohydrate

双氯西林钠水合物

Report date: 2023/01/13 20:00:32

Base Information

Drug NameDicloxacillin sodium monohydrate
Drug Alias Name双氯青霉素PathocilDynapenP-1011
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsDermatitisSoft Tissue InfectionsRespiratory Tract Infections +[5] 
Global Approved IndicationsStaphylococcal Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesDenmarkEU +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Southern DenmarkBright Future Pharmaceuticals FactoryHong Kong Aomei Pharmaceutical Factory Co Ltd Beijing Representative Office
Inactive CompaniesWyeth-Ayerst
Active IndicationsDermatitisSoft Tissue InfectionsRespiratory Tract Infections +[4] 
Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeJ01CF01
Related LinksWikipediaDrugBankKEGG